Anti-infective drug therapy in ophthalmology - Part 2: Viral infections;Antiinfektive medikamentöse therapie in der augenheilkunde - Teil 2: Virale infektionen

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 2, 2005, Pages 81-89

  Reinhard, T ^a   Hansen, L L ^a   Pache, M ^a   Behrens Baumann, W ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Augenklinik Universitatsklinikums   (Germany)

Author keywords

Adenovirus; Antivirals; Cytomegaly virus; Epstein Barr virus; Herpes simplex virus; Keratitis; Retinitis; Uveitis; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CYCLOSPORIN A; FLUOCORTOLONE CAPROATE; FOSCARNET; GANCICLOVIR; IDOXURIDINE; IMMUNOMODULATING AGENT; TRIFLURIDINE; VALACICLOVIR;

ADENOVIRUS; CLINICAL RESEARCH; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; EYE INFECTION; HERPES SIMPLEX VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; PROSPECTIVE STUDY; REVIEW; TREATMENT INDICATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ANTIVIRAL AGENTS; EYE INFECTIONS, VIRAL; HUMANS; OPHTHALMOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS;

EID: 14744274586     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-857935     Document Type: Review

References (64)

1. Ahmed I, Ai E. Medical management of cytomegalovirus retinitis. Ophthalmol Clin North Am 1997; 10: 15-25
2. Akler ME, Johnson DW, Burman WJ et al. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology 1998; 105: 651 -657
3. Ameye C, Sundmacher R, De Clerq E. Topical BVDU plus low-dosage steroids in the treatment of chronic relapsing zoster keratouveitis. A pilot study. Graefe's Arch Gin Exp Ophthalmol 1989; 227: 118-122
4. Barren BA, Gee L, Hauck WW et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1871-1882
5. Behrens-Baumann W, Weber U, Ansorg R. Aciclovir und bakterielle Hornhautinfektion. Eine tierexperimentelle Studie. Ber Dtsch Ophthalmol Ces 1981; 78: 399-401
6. Behrens-Baumann W. Phosphonoformate (Foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial. Acta Ophthalmol 1992; 70: 690-692
7. Centifanto-Fitzgerald YM, Fenger T, Kaufman HE. Virus proteins in herpetic keratitis. Exp Eye Res 1982; 35: 425-441
8. Centifanto-Fitzgerald YM, Yamaguchi T, Kaufman HE et al. Ocular disease pattern induced by herpes simplex virus is genetically determined by specific region of viral DNA. J Exp Med 1982; 155: 475-489
9. Chodosh J, Astley RA, Butler MG et al. Adenovirus keratitis: A role for interleukin-8. Invest Ophthalmol Vis Sci 2000; 41: 783-789
10. Cohen EJ, Rapuano CJ, Laibson PR. External Diseases. In: Tasman W, Jaeger EA (Hrsg). The Wills Eye Hospital atlas of clinical ophthalmology. Philadelphia, USA: Lippincott-Raven Publishers, 1996: 17-19
11. Colin J, Hoh HB, Easty DL et al. Ganciclovir ophthalmic gel (Virgan; 0,15%) in the treatment of herpes simplex keratitis. Cornea 1997; 16: 393-399
12. Collum LM, Logan P, Ravenscroft T. Acyclovir in herpetic disciform keratitis. Br J Ophthalmol 1983; 67: 115-117
13. Collum LM, McGettrick P, Akhtar J et al. Oral acyclovir in herpes simplex dendritic corneal ulceration. Br J Ophthalmol 1986; 70: 435-438
14. Corey L, Whitley RJ, Stone EF et al. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988; January 2: 1-4
15. Crouse CA, Pflugfelder SC, Pereira I et al. Detection of herpes viral genomes in normal and diseased corneal epithelium. Curr Eye Res 1990; 9: 569-581
16. Culbertson WW, Blumenkranz MS, Pepose JS et al. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology 1986; 93: 559-569
17. Culbertson WW, Atherton SS. Acute retinal necrosis and similar retinitis syndromes. Ophthalmology 1993; 33: 129-143
18. Culbertson WW, Dix RD. Varicella-Zoster Virus diseases: Posterior Segment of the Eye. In: Pepose JS, Holland GN, Williams KR (Hrsg). Ocular Infection and Immunology. St Louis, USA: Mosby, 1996: 1131-1154
19. Dawson CR, Togni B. Herpes simplex eye infections. Clinical manifestation, pathogenesis and management. Surv Opthalmol 1976; 21: 121-135
20. Engstrom RE Jr, Holland GN, Margolis TP et al. The progressive outer retinal necrosis syndrome: a variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994; 101: 1488-1502
21. Gerling J, Neumann-Haefelin D, Seuffert HM et al. Diagnosis and management of the acute reinal necrosis syndrome. Ger J Ophthalmol 1992; 1: 388-393
22. Günther R. Pathologisch-anatomischer Befund einer Hornhaut bei Keratitis epidemica. Klin Monatsbl Augenheilk 1939; 103: 309-314
23. Hansen LL. Retinale Erkrankungen bei AIDS. Ophthalmologe 1993; 90: 239-249
24. Hansen LL. HIV-Infektion und Auge. Ophthalmologe 2000; 97: 718-736
25. Herpetic Eye Disease Study Group. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1883-1895
26. Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol 1996; 114: 1065-1072
27. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998; 339: 340-341
28. Hillenkamp J, Reinhard T, Ross RS et al. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% Cidofovir and 1% Cyclosporin A: A controlled clinical pilot study. Arch Ophthalmol 2001; 109: 845-850
29. Hillenkamp J, Reinhard T, Ross RS et al. The effects of Cidofovir 1% with and without Cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis. A controlled clinical pilot study. Ophthalmology 2002; 109: 845-850
30. Hoh HB, Hurley C, Claoue C et al. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. Br J Ophthalmol 1996; 80: 140-142
31. Holland EJ, Mozayeni RM, Schwartz GS. Herpes simplex keratitis. In: Krachmer JH, Mannis MJ, Holland EJ (Hrsg). Cornea. St Louis, Missouri, USA: Mosby.1997: 1191-1223
32. Holland GN. Executive committee of the American uveitis society. Standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 1994; 117: 663-667
33. Kaufman HE, Centifanto-Fitzgerald YM, Varnell ED. Herpes simplex keratitis. Ophthalmology 1983; 90: 700-706
34. Kersten A, Reinhard T, Sundmacher R. Postoperative Komplikationen nach perforierender Keratoplastik in Herpesaugen. Ophthalmologe 1997; 94: 889-896
35. Lalezari JP. Cidofovir: a new therapy for cytomegalovirus retinitis. J Acqu Imm Def Syndr Hum Retrovirol 1997; 14 (S1): 22-26
36. Liesegang TJ. Herpes zoster keratitis. In: Krachmer JH, Mannis MJ, Holland EJ (Hrsg). Cornea. St Louis, Missouri, USA: Mosby, 1997: 1225-1242
37. Lund OE, Stefani FH. Corneal histology after epidemic keratoconjunctivitis. Arch Ophthalmol 1978; 96: 2085-2088
38. Margolis TP, Atherton SS. Herpes simplex virus diseases: posterior segment of the eye. In: Pepose JS, Holland GN, Williams KR (Hrsg). Ocular Infection and Immunology. St Louis, USA: Mosby, 1996: 1155-1167
39. Maugdal PC, De Clerq E, Missotten L. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella zoster virus in eye infections. Antiviral Res 1984; 4: 281-291
40. Maugdal PC, Dieltiens M, De Clerq E et al. Topical Bromovinyldeoxyuridine treatment of herpes simplex keratitis. In: Maugdal PC, Missotten L (Hrsg). Herpetic eye diseases. Dordrecht: Junk, 1985: 247-255
41. Mayer K, Reinhard T, Reis A et al. Synergistic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease. Graefe's Arch Clin Exp Ophthalmol 2003; 241: 1051-1054
42. Nahmias AJ, Visintine AM, Caldwell DR et al. Eye infections with herpes simplex viruses in neonates. Surv Ophthalmol 1976; 21: 100-105
43. Neoh C, Harding SP, Saunders D et al. Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus. Eye 1994; 8: 688-691
44. Palay DA, Sternberg P Jr, Davis J et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol 1991; 112: 250-255
45. Reinhard T, Godehadt E, Pfahl HG et al. Lokales Cyclosporin A bei Nummuli nach Keratoconjunktivitis epidemica. Eine Pilotstudie. Ophthalmologe 2000; 97: 764-768
46. Reinhard T, Reis A, Mayweg S et al. Lokales FK506 bei entzündlichen Erkrankungen von Hornhaut und Bindehaut. Klin Monatsbl Augenheilk 2002; 219: 125-131
47. Reinhard T, Adams O, Sundmacher R. Detection of the Epstein-Barr virus genome in the anterior chamber of a patient with chronic uveitis. Acta Ophthalmol 2003; 81: 671-673
48. Rossa V, Sundmacher R. Lokale Interferonprophylaxe einer "epidemischen" Konjunktivitis durch ein nicht identifizierbares Virus. Klin Monatsbl Augenheilk 1991; 199: 192-194
49. Smeraglia R, Hoachadel J, Varnell ED et al. The role of herpes simplex virus secreted glycoproteins in herpetic keratitis. Exp Eye Res 1982; 35: 443-459
50. Sundmacher R, Neumann-Haefelin D, Cantell D. Interferon treatment of dendritic keratitis. Lancet 1976; 1: 1406
51. Sundmacher R, Cantell K, Haug P et al. Role of debridement and interferon in the treatment of dendritic keratitis. Graefe's Arch Clin Exp Ophthalmol 1978; 207: 77-82
52. Sundmacher R, Neumann-Haefelin D, Cantell K. Trials with interferon in ophthalmic zoster. In: Sundmacher R (Hrsg). Herpetische Augenerkrankungen. München: Bergmann Verlag, 1981: 465-468
53. Sundmacher R. A clinico-virologic classification of herpetic anterior segment diseases with special reference to intraocular herpes. In: Sundmacher R (Hrsg). Herpetische Augenerkrankungen. München: Bergmann Verlag, 1981: 203-210
54. Sundmacher R. Orale Acyclovir-Theapie von i. o. Herpes simplex Virus Infektionen. Klin Monatsbl Augenheilk 1983; 183: 246-250
55. Sundmacher R. Therapie der herpetischen Erkrankungen des vorderen Augenabschnitts. Klin Monatsbl Augenheilk 1985; 186: 421-425
56. Sundmacher R, Engelskirchen U. Zum Problem der rezidivierenden und persistierenden Numuli nach Keratoconjunctivitis epidemica. Klin Monatsbl Augenheilk 1991; 198: 550-554
57. Sundmacher R, Hillenkamp J, Reinhard T. Perspektiven von Therapie und Prophylaxe der Adenoviruskeratokonjunktivitis. Ophthalmologe 2001; 98: 991-1009
58. Stamler JF. Viral conjunctivitis. In: Krachmer JH, Mannis MJ, Holland EJ (Hrsg). Cornea. St. Louis, Missouri, USA: Mosby, 1997: 773-777
59. Trauzettel-Klosinski S, Sundmacher R, Wigand R. Die Wirkung von Steroiden bei Keratoconjunctivitis epidemica. Klin Monatsbl Augenheilk 1980; 176: 899-906
60. Tsai CS, Ritch R, Straus SE et al. Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome. Arch Ophthalmol 1990; 108: 1572-1576
61. Uruyama A, Yamada N, Sasaki T et al. Unilateral acute uveitis with retinal periarteritis and detachment. Jpn Clin Ophthalmol 1971; 25: 607-629
62. Wander AH, Centifanto YM, Kaufman HE. Strain specifity of clinical isolates of herpes simplex virus. Arch Ophthalmol 1980; 98: 1458-1461
63. Wilhelmus KR. Interventions for herpes simplex virus epithelial keratitis. The Cochrane database of systematic reviews 2004
64. Zimmer C, Nieuwenhuis I, Danisevskis M et al. Plötzliche Erblindung bei einem AlDS-Patienten. Klin Mbl Augenheilk 1991; 199: 48-52